Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20038235 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Safety Study in Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia, Lymphocytic, Chronic
Intervention: Drug: SGN-40 (anti-huCD40 mAb)

Indicates status has not been verified in more than two years